Literature DB >> 23719171

Efficacy and tolerability of Day 2 manipulation and local anaesthesia after collagenase injection in patients with Dupuytren's contracture.

C J Manning1, R Delaney2, M J Hayton3.   

Abstract

In clinical trials, treating Dupuytren's contracture with collagenase injection involves manipulation the day after injection, without local anaesthesia. We evaluated the efficacy and tolerability of manipulation 2 days after injection with local anaesthesia. Forty-five patients received 50 injections into cords contracting metacarpophalangeal and proximal interphalangeal joints; follow-up visits were at 3 and 14 weeks. For the metacarpophalangeal joints there were >90% reduction in contracture at both visits. The proximal interphalangeal joints that improved spontaneously after metacarpophalangeal injection or received direct injections showed 51-55% reduction in contracture. Changes in scores on the Patient Evaluation Measure suggest that patients perceived improvements in their hand function was good and they were satisfied with the procedure. Collagenase and local anaesthesia injections were well tolerated; adverse events were localized to the injection site and were mild and transient in nature. These findings provide another viable option for practising surgeons and may help with the logistics of patient care.
© The Author(s) 2013.

Entities:  

Keywords:  Collagenase; Dupuytren’s contracture; Dupuytren’s disease; changes in fixed-flexion contracture; day 2 manipulation; finger extension procedure; local anaesthetic; manipulation; patient evaluation measure

Mesh:

Substances:

Year:  2013        PMID: 23719171     DOI: 10.1177/1753193413490899

Source DB:  PubMed          Journal:  J Hand Surg Eur Vol        ISSN: 0266-7681


  10 in total

1.  Complications Following Collagenase Treatment for Dupuytren Contracture.

Authors:  Jennifer Wozniczka; Clifford Canepa; Adam Mirarchi; Joel S Solomon
Journal:  Hand (N Y)       Date:  2017-06-21

2.  Clinical outcomes following collagenase injections compared to fasciectomy in the treatment of Dupuytren's contracture.

Authors:  Raghuveer C Muppavarapu; Michael J Waters; Matthew I Leibman; Mark R Belsky; David E Ruchelsman
Journal:  Hand (N Y)       Date:  2015-06

Review 3.  Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.

Authors:  Francesco Smeraglia; Angelo Del Buono; Nicola Maffulli
Journal:  Br Med Bull       Date:  2016-05-05       Impact factor: 4.291

4.  Delayed manipulation after collagenase clostridium histolyticum injection for Dupuytren contracture.

Authors:  F Thomas D Kaplan; Marie A Badalamente; Lawrence C Hurst; Gregory A Merrell; Raymond Pahk
Journal:  Hand (N Y)       Date:  2015-09

5.  Collagenase treatment of Dupuytren's contracture using a modified injection method: a prospective cohort study of skin tears in 164 hands, including short-term outcome.

Authors:  Isam Atroshi; Jesper Nordenskjöld; Anna Lauritzson; Eva Ahlgren; Johanna Waldau; Markus Waldén
Journal:  Acta Orthop       Date:  2015-02-19       Impact factor: 3.717

6.  Difference in Success Treating Proximal Interphalangeal and Metacarpophalangeal Joints with Collagenase: Results of 208 Treatments.

Authors:  Karina Liv Hansen; Jens Christian Werlinrud; Søren Larsen; Tune Ipsen; Jens Lauritsen
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-04-25

7.  Cost-Effectiveness and Patient Outcomes of Injectable Collagenase to Treat Dupuytren's Contracture.

Authors:  Rajpreet S Sahemey; Govind S Dhillon; Karanjeet S Sagoo; Kuntrapaka Srinivas
Journal:  Cureus       Date:  2021-12-20

8.  Costs for collagenase injections compared with fasciectomy in the treatment of Dupuytren's contracture: a retrospective cohort study.

Authors:  Isam Atroshi; Emelie Strandberg; Anna Lauritzson; Eva Ahlgren; Markus Waldén
Journal:  BMJ Open       Date:  2014-01-15       Impact factor: 2.692

9.  Collagenase clostridium histolyticum in patients with Dupuytren's contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes.

Authors:  D Warwick; M Arner; G Pajardi; B Reichert; Z Szabo; E H Masmejean; J Fores; D S Chapman; R A Gerber; F Huard; A Seghouani; P P Szczypa
Journal:  J Hand Surg Eur Vol       Date:  2014-01-26

10.  Collagenase injections for Dupuytren disease: 3-year treatment outcomes and predictors of recurrence in 89 hands.

Authors:  Jesper Nordenskjöld; Anna Lauritzson; Anna Åkesson; Isam Atroshi
Journal:  Acta Orthop       Date:  2019-09-10       Impact factor: 3.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.